Navigation Links
Pharmaceuticals Announces $1.5 Million Second Closing in Private Placement
Date:1/31/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., Jan. 31, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the second closing in a private placement consisting of approximately 1.9 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.5 million. The total amount raised in the private placement is $6.9 million.

DelMar announced a first closing of $5.4 million on January 25, 2013.

Charles Vista LLC acted as the company's placement agent in the unit offering. Each unit consists of one share of common stock and one common stock purchase warrant.

Jeffrey Bacha , Chief Executive Officer of DelMar, commented "We are pleased to announce this second closing to raise additional funds and are very encouraged by the overall level of investor interest in our private placement. We continue to enhance our financial position to expand and accelerate our drug development activities with our lead drug candidate, VAL-083." 

About DelMar Pharma
Del Mar Pharmaceuticals was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.  VAL-083 benefits from extensive clinical research sponsored by the US National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action.

Safe Harbor Statement
Any state
'/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...  Edelberg & Associates (EA) and ScribeAmerica today ... medical coding software platform designed to engage and ... coder at the point of care.  In a ... has successfully built, deployed and tested a new ... and medical coder that can radically improve natural ...
(Date:3/30/2015)... , March 30, 2015 DURECT Corporation ... has initiated a multi-dose Phase 1 clinical trial ... molecule in DURECT,s Epigenomic Regulator Program.  DUR-928 is ... may have broad applicability in metabolic diseases such ... steatohepatitis (NASH).  It may also play an important ...
(Date:3/30/2015)... , March 30, 2015   GlassesUSA , the ... closing of $12.5 million in new financing led by ... The funding will further GlassesUSA,s aggressive business growth and accelerate ... market of online eyewear, both B2C and B2B. ... , COO Eldad Rothman , and CTO Roy ...
Breaking Medicine Technology:Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 2Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
(Date:3/30/2015)... 31, 2015 NAPW honors ... Woman of the Year. Ms. Irey is recognized with ... largest, most-recognized networking organization of professional women in the ... Association of Professional Women is a powerfully vibrant networking ... Chapters. , “I take care of four offices, 24 ...
(Date:3/30/2015)... The AAAHC, a private, non-profit ... provision of high-quality health care through the development ... accreditation programs for 35 years. Through a peer-based ... promote excellence in patient safety and care. Outpatient ... on-site evaluations by AAAHC expert surveyors, doctors, nurses, ...
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 Healthpointe ... screens for employers and companies throughout Southern ... applicants are using drugs. It can identify evidence ... drugs. Employers, sports teams, D.O.T. applicants, and students regularly ... , The features of the drug screen program at ...
(Date:3/30/2015)... Foundations Recovery Network, an innovative behavioral ... of its 41st national conference by hosting the groundbreaking ... Congressman Patrick J. Kennedy as keynote speakers at the ... San Diego, CA, March 30 - April 2, 2015 ... together leading experts specializing in the treatment of substance ...
(Date:3/30/2015)... March 30, 2015 The pharmaceutical business ... flexible biological manufacturing plants. This is primarily due to ... , This has forced facilities to produce and perform ... existing facilities have been forced to expand production, change ... of ownership. , Most of these facilities have remained ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Stacey Lynne Irey, Office Manager at Mid Jersey Endodontic Group, a 2015 Professional Woman of the Year 2Health News:Precinct Ambulatory Surgery Center Achieves Accreditation Association for Ambulatory Health Care Accreditation 2Health News:Drug Screens Now at Healthpointe 2Health News:Drug Screens Now at Healthpointe 3Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 3
... 2011) -- In the longest study of its kind, bariatric ... attack and stroke in patients with diabetes. These results and ... on Interventional Therapies for Type 2 Diabetes, hosted by NewYork-Presbyterian ... watershed moment for diabetes care. With 20 years of data, ...
... of Rheumatology has developed new guidelines for starting and ... are the first JIA guidelines endorsed by the ACR, ... community. Created as a guide for health ... safety monitoring of multiple medications used in the treatment ...
... Most people have had trouble remembering something they just heard. ... have something to do with being in a good mood. ... of Arts and Science, has found that being in a ... memory, for example, is the ability to recall items in ...
... a computer model of the crowded interior of a bacterial ... sugar in its environment accurately simulates the behavior of ... result of a collaboration between experimental scientists at the Max ... the University of Illinois using the newest GPU (graphics processing ...
... , WEDNESDAY, March 30 (HealthDay News) -- ... associated with larger brain growth in offspring, which explains ... so long, say researchers. They also said the ... mammal species offer further proof that breast-feeding is good ...
... UT Southwestern Medical Center have discovered genetic pathways to starve ... both rare and common cases of kidney cancer may be ... cells from generating the energy needed to survive. In one ... of the journal Oncogene , researchers found that inactivating ...
Cached Medicine News:Health News:Bariatric surgery reduces long-term cardiovascular risk in diabetes patients 2Health News:Bariatric surgery reduces long-term cardiovascular risk in diabetes patients 3Health News:Bariatric surgery reduces long-term cardiovascular risk in diabetes patients 4Health News:New clinical practice guidelines developed for juvenile idiopathic arthritis 2Health News:New clinical practice guidelines developed for juvenile idiopathic arthritis 3Health News:Being in a good mood may lead to poor memory 2Health News:Researchers make the leap to whole-cell simulations 2Health News:Researchers make the leap to whole-cell simulations 3Health News:Longer Breast-Feeding May Be Key to Bigger Brains 2Health News:UT Southwestern research advances fight against kidney cancer 2Health News:UT Southwestern research advances fight against kidney cancer 3
... oral. Marked with recommended tube size ... Graduated. Single use. For improved surgical ... the tube by incorporating a preformed ... anatomical situation at body temperature. AGT ...
Cuffed pediatric endotracheal tubes, available from 2.5 mm to 4.5 mm inside diameter. Ruschelit® PVC. Magill tip - nasoral. X-ray opaque line. Graduated. Single use. Sterile...
... Slick Set® Tube with stylet ... A quality uncuffed Rusch endotracheal tube ... ready to use saving you time ... color coded for easy identification and ...
Ruschelit® PVC. Murphy eye-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Medicine Products: